40 participants
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-06
- Start Date:
- 2026-04-21
- Completion:
- 2027-12-31
Conditions
- Acute Myeloid Leukemia
Interventions
- PROCEDURE
- DRUG
- OTHER
No Results Yet